Physician profile
Deborah Ann Torrence
NPI 1467020297
$2,785.46
in general payments reported to CMS, 2019-2025
22 companies · $457 in 2025
The $457 reported for 2025 was more than what a typical Gerontology (Nurse Practitioner) provider received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $171 · 2022: $668 · 2023: $849 · 2024: $641 · 2025: $457.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,947.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,946.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $875.14 | 2021-2024 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $512.84 | 2022-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $184.69 | 2022-2025 | |
| E.R. Squibb & Sons, L.L.C. | $155.83 | 2022-2023 | Camzyos, Eliquis |
| Novo Nordisk INC | $151.39 | 2023 | Ozempic, Rybelsus |
| Amgen INC. | $136.18 | 2021-2025 | Repatha, Repatha |
| Gilead Sciences, INC. | $123.97 | 2024 | Veklury |
| Abbvie INC. | $100.82 | 2023 | |
| Boston Scientific Corporation | $94.65 | 2022-2024 | Watchman Flx |
| Abiomed | $69.36 | 2024-2025 | Impella |
| Bayer Healthcare Pharmaceuticals INC. | $69.35 | 2023-2025 | |
| Pfizer INC. | $46.30 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $44.53 | 2021-2023 | Farxiga |
| Lexicon Pharmaceuticals, INC. | $41.35 | 2024 | |
| Alnylam Pharmaceuticals INC. | $26.81 | 2024 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kiniksa Pharmaceuticals International, Plc | $25.25 | 2024 | Arcalyst |
| Kestra Medical Technology Services, INC. | $24.92 | 2023 | Assure Wcd |
| Edwards Lifesciences Corporation | $24.77 | 2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Cvrx, INC. | $21.33 | 2025 | Barostim Neo System |
| Glaxosmithkline, LLC. | $19.65 | 2025 | Shingrix, Arexvy |
| Bridgebio Pharma, INC. | $18.92 | 2025 | Attruby |
| Sanofi-Aventis U.S. LLC | $17.41 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deborah Torrence listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.